ApprovalTrail

Approval · Notice of Compliance 19100 · 2017

CYCLOSPRAY: Notice of Compliance 19100

Issued March 27, 2017

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
19100
Date
March 27, 2017
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Other

Products in this notice

BrandDINStatus today
CYCLOSPRAY02462419Marketed

Medicinal ingredients